These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Mechanistic insights into influenza vaccine-associated narcolepsy. Ahmed SS; Steinman L Hum Vaccin Immunother; 2016 Dec; 12(12):3196-3201. PubMed ID: 27031682 [TBL] [Abstract][Full Text] [Related]
3. Comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2". Vassalli A; Li S; Tafti M Sci Transl Med; 2015 Nov; 7(314):314le2. PubMed ID: 26582896 [TBL] [Abstract][Full Text] [Related]
4. Antigenic differences between AS03 adjuvanted influenza A (H1N1) pandemic vaccines: implications for pandemrix-associated narcolepsy risk. Vaarala O; Vuorela A; Partinen M; Baumann M; Freitag TL; Meri S; Saavalainen P; Jauhiainen M; Soliymani R; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Rouvinen J; Roivainen M; Nohynek H; Jokinen J; Julkunen I; Kilpi T PLoS One; 2014; 9(12):e114361. PubMed ID: 25501681 [TBL] [Abstract][Full Text] [Related]
5. Autoantibodies against ganglioside GM3 are associated with narcolepsy-cataplexy developing after Pandemrix vaccination against 2009 pandemic H1N1 type influenza virus. Saariaho AH; Vuorela A; Freitag TL; Pizza F; Plazzi G; Partinen M; Vaarala O; Meri S J Autoimmun; 2015 Sep; 63():68-75. PubMed ID: 26227560 [TBL] [Abstract][Full Text] [Related]
6. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010. Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154 [TBL] [Abstract][Full Text] [Related]
7. Response to comment on "Antibodies to influenza nucleoprotein cross-react with human hypocretin receptor 2". Steinman L; Ahmed SS Sci Transl Med; 2015 Nov; 7(314):314lr2. PubMed ID: 26582897 [TBL] [Abstract][Full Text] [Related]
8. Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases. Luo G; Lin L; Jacob L; Bonvalet M; Ambati A; Plazzi G; Pizza F; Leib R; Adams CM; Partinen M; Mignot EJ PLoS One; 2017; 12(12):e0187305. PubMed ID: 29220370 [TBL] [Abstract][Full Text] [Related]
9. Broadly protective immunity against divergent influenza viruses by oral co-administration of Lactococcus lactis expressing nucleoprotein adjuvanted with cholera toxin B subunit in mice. Lei H; Peng X; Jiao H; Zhao D; Ouyang J Microb Cell Fact; 2015 Aug; 14():111. PubMed ID: 26242406 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Pandemrix and Arepanrix, two pH1N1 AS03-adjuvanted vaccines differentially associated with narcolepsy development. Jacob L; Leib R; Ollila HM; Bonvalet M; Adams CM; Mignot E Brain Behav Immun; 2015 Jul; 47():44-57. PubMed ID: 25452148 [TBL] [Abstract][Full Text] [Related]
11. Vaccination and narcolepsy: Immune link found? Wekerle H Sci Transl Med; 2015 Jul; 7(294):294fs27. PubMed ID: 26136475 [TBL] [Abstract][Full Text] [Related]
12. Antibody Affinity Against 2009 A/H1N1 Influenza and Pandemrix Vaccine Nucleoproteins Differs Between Childhood Narcolepsy Patients and Controls. Lind A; Freyhult E; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Lima Bomfim I; Fink K; Fex M; Törn C; Elding Larsson H; Lernmark Å Viral Immunol; 2017 Oct; 30(8):590-600. PubMed ID: 28796576 [TBL] [Abstract][Full Text] [Related]
13. No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland. Melén K; Partinen M; Tynell J; Sillanpää M; Himanen SL; Saarenpää-Heikkilä O; Hublin C; Olsen P; Ilonen J; Nohynek H; Syrjänen R; Kilpi T; Vuorela A; Kirjavainen T; Vaarala O; Julkunen I PLoS One; 2013; 8(8):e68402. PubMed ID: 23950869 [TBL] [Abstract][Full Text] [Related]
15. No evidence of autoimmunity to human OX Melén K; Jalkanen P; Kukkonen JP; Partinen M; Nohynek H; Vuorela A; Vaarala O; Freitag TL; Meri S; Julkunen I J Transl Autoimmun; 2020; 3():100055. PubMed ID: 32743535 [TBL] [Abstract][Full Text] [Related]
16. Enhanced influenza A H1N1 T cell epitope recognition and cross-reactivity to protein-O-mannosyltransferase 1 in Pandemrix-associated narcolepsy type 1. Vuorela A; Freitag TL; Leskinen K; Pessa H; Härkönen T; Stracenski I; Kirjavainen T; Olsen P; Saarenpää-Heikkilä O; Ilonen J; Knip M; Vaheri A; Partinen M; Saavalainen P; Meri S; Vaarala O Nat Commun; 2021 Apr; 12(1):2283. PubMed ID: 33863907 [TBL] [Abstract][Full Text] [Related]
17. Impact of cytokine in type 1 narcolepsy: Role of pandemic H1N1 vaccination ? Lecendreux M; Libri V; Jaussent I; Mottez E; Lopez R; Lavault S; Regnault A; Arnulf I; Dauvilliers Y J Autoimmun; 2015 Jun; 60():20-31. PubMed ID: 25892508 [TBL] [Abstract][Full Text] [Related]
18. Antibodies Against Hypocretin Receptor 2 Are Rare in Narcolepsy. Giannoccaro MP; Waters P; Pizza F; Liguori R; Plazzi G; Vincent A Sleep; 2017 Feb; 40(2):. PubMed ID: 28364500 [TBL] [Abstract][Full Text] [Related]
19. [Narcolepsy with cataplexy: an autoimmune disease?]. Jacob L; Dauvilliers Y Med Sci (Paris); 2014 Dec; 30(12):1136-43. PubMed ID: 25537044 [TBL] [Abstract][Full Text] [Related]
20. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]